Amole

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amole

Amole is a medicinal product defined by its active ingredient, Acetaminophen. It is also known as Paracetamol (the International Nonproprietary Name). It is classified primarily as a Non-Opioid Analgesic and an Antipyretic agent. The preparation is a widely used first-line medicine globally, recognized for addressing general discomforts.

Amole: Classification, Active Ingredient, and Identity

The definitive substance in Amole is Acetaminophen, chemically synonymous with Paracetamol and often abbreviated as APAP. This classification signifies the drug's dual pharmacological role: as an analgesic, it works to relieve pain, and as an antipyretic, it reduces fever. Acetaminophen, unlike many Nonsteroidal Anti-inflammatory Drugs (NSAIDs), lacks significant anti-inflammatory activity and primarily targets the Central Nervous System. This differentiation is based on its central mechanism of action.

Composition and Pharmaceutical Forms of Amole

The core active compound, Acetaminophen, is synthetic in origin, derived from the Para-Aminophenol chemical family. Amole is generally manufactured as a single-ingredient product, though it may be compounded with other substances in specific formulations. A key feature of preparations like Amole is its availability across various dosage forms targeting specific patient demographics, particularly the oral liquid forms which are often formulated for pediatric patient groups. These forms facilitate different routes of administration, including common oral solid preparations (e.g., tablets), and specialized forms for rectal or parenteral delivery. The specific base or vehicle used depends on the preparation's intended delivery system.

General Therapeutic Purpose

The overarching purpose of Amole is to provide symptomatic relief by addressing pain and fever. Its core function is to mitigate the subjective discomfort caused by aches, pains, and elevated body temperature. A typical use scenario involves relieving the malaise and fever associated with the common cold. By exerting its therapeutic action on the central processing of these symptoms, Amole is used for the transient relief of widespread discomfort.

What side effects are possible with Amole?

Official Safety Profile and Adverse Reactions

The official safety profile for Amole (Acetaminophen/Paracetamol) is structured around the potential for severe adverse reactions, which are classified by system-organ class (SOC) and frequency based on regulatory documents.

System-Organ Classes and Frequency

Adverse effects are documented across several systems, with Hepatobiliary Disorders being the most critical concern. Reactions are typically categorized as Rare or Very Rare in therapeutic use:

  • Rare: Includes certain Blood and Lymphatic System Disorders (e.g., thrombocytopenia, agranulocytosis) and non-severe Hypersensitivity Reactions (like rash or urticaria).
  • Very Rare: Includes life-threatening systemic reactions such as Anaphylactic Shock and Severe Cutaneous Adverse Reactions (SCARs, including SJS, TEN, and AGEP) under Immune System and Skin Disorders.

Serious Adverse Reactions

The single most significant safety statement documented in regulatory labeling is the risk of Acute Liver Failure and Hepatotoxicity. This risk is primarily linked to the ingestion of a dose that exceeds the recommended therapeutic limit, though it remains the central serious safety consideration. Serious SCARs are also officially documented as requiring vigilance throughout the course of treatment.

Safety Constraints and Special Populations

Official labeling defines specific safety constraints, particularly for patients with compromised liver health. Individuals with severe hepatic impairment are constrained from use due to the risk of exacerbating liver damage. Furthermore, chronic heavy alcohol consumption is officially documented as a risk factor that can increase susceptibility to hepatotoxicity, even when using the medicine within standard therapeutic boundaries. Renal damage is also noted as a safety pattern associated with prolonged, continuous, high-dose exposure.

Overdose and Emergency Response

The regulatory profile for Amole (Acetaminophen/Paracetamol) overdose is defined by the critical, time-sensitive risk of severe liver damage (Hepatotoxicity), which can progress to Acute Liver Failure and ultimately result in death. Overdose is considered a medical emergency.

Documented Overdose Manifestations

Overdose presentations are initially non-specific, often beginning with mild symptoms such as nausea, vomiting, abdominal discomfort, loss of appetite, and general malaise. These early signs may be minimal or absent. However, as documented in official labeling, a delayed presentation can include more severe manifestations, such as jaundice, confusion, somnolence, and the need for hospital monitoring. Individuals with pre-existing liver disease or chronic malnutrition are considered to be at increased risk of severe outcomes.

When to Seek Immediate Help

Because of the potential for life-threatening complications, immediate medical attention must be sought if an Amole overdose is suspected. Contact a Poison Control Center or emergency services right away, even if the person appears to feel well, as clinical damage may occur before severe symptoms appear. The specific antidote, N-acetylcysteine, is administered in a hospital setting based on plasma concentration tests and continuous monitoring of hepatic and renal function. Rapid intervention is crucial for effective management.

Therapeutic Uses of Amole

Amole (Acetaminophen/Paracetamol) is generally used as an analgesic and antipyretic agent, and is commonly used to help with symptomatic relief across commonly encountered conditions. It is utilized to help with symptoms related to physical discomfort and systemic imbalance. It is relevant in conditions characterized by periods of heightened symptoms, such as headache, backache, muscular aches, dental pain, and the discomfort of menstrual cramps. Amole is applicable within clinical settings that involve acute or disruptive symptom patterns, notably those characterized by systemic elevated body temperature (fever).

Quick Fact: Relief for Fever and Mild Pain

The medication's role is centered on managing mild to moderate discomfort and helping to reduce fever associated with colds and influenza or other common illnesses. This action offers symptomatic relief that assists patients in coping more steadily with difficult episodes and supports the maintenance of stability when symptoms are more noticeable. The therapeutic benefit extends to situations requiring short-term symptomatic assistance, such as managing acute pain following minor procedures.

“Amole is commonly used when short-term symptomatic assistance is needed and may assist with maintaining functional stability.”

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Amole (Acetaminophen/Paracetamol)

Eligibility Scope

The use of Amole (Acetaminophen/Paracetamol) is generally established for the adult and adolescent population. Contraindications strictly prohibit use in patients with known hypersensitivity to the medicine or excipients, or those with severe active liver disease or severe hepatic impairment.

Condition-specific eligibility rules

Official labeling requires caution and may necessitate conditional use restrictions for populations with existing organ impairment. This includes patients with moderate hepatic insufficiency (such as Gilbert's syndrome), severe renal insufficiency (with low creatinine clearance), chronic alcoholism, or physiological states associated with glutathione depletion, such as severe malnutrition. The maximum allowed use may also be restricted for certain adults with low body weight (e.g., less than 50 kg).

Age and Reproductive Eligibility

While appropriate for general use, specific high-dose formulations are typically not recommended for children under 10 years of age. During pregnancy and lactation, the medicine is considered conditionally permitted by regulatory authorities if clinically required. Use should adhere to the principle of employing the lowest effective dose for the shortest possible duration.

Connection to the overall eligibility profile

Official regulatory documents define Amole's eligibility profile by categorizing populations into those with established use, those for whom use is conditionally restricted due to organ function or metabolic conditions, and those for whom use is absolutely prohibited due to hypersensitivity or severe underlying liver disease.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory documentation structures the interaction profile of Amole based on its potential for altered exposure when co-administered with certain substance classes. These interactions primarily involve changes to drug metabolism and transport.

Key Interaction Categories

The most significant interactions involve medicines that influence specific liver enzymes (Cytochrome P450, or CYP) and drug transporters (P-glycoprotein, or P-gp). Official labeling details constraints for these categories:

  • Strong Inducers of CYP Enzymes (e.g., CYP3A4, CYP2C19): Co-administration with strong enzyme inducers is generally restricted or required to be avoided. This is because inducers can significantly decrease Amole exposure, potentially diminishing its effects.
  • Strong Inhibitors of CYP Enzymes (e.g., CYP3A4, CYP2C19): Concomitant use with strong enzyme inhibitors requires specific clinical monitoring or alternative management, as inhibitors can increase Amole exposure.
  • P-glycoprotein (P-gp) Modulators: Products that induce or inhibit the P-gp transporter necessitate specific regulatory requirements for management or avoidance to prevent changes in drug concentrations.

Administration and Timing Constraints

Regulatory information also addresses interactions related to administration timing:

  • Products Affecting Gastric pH: Medicines that alter the acidity of the stomach (acid-reducing agents) may reduce Amole absorption. Official labeling requires staggering the administration of these agents relative to Amole.
  • Dietary Products: The consumption of specific food products or dietary supplements, such as grapefruit, is restricted or required to be avoided due to a documented effect on Amole pharmacokinetics.

Mechanism of Action

Selective Enzyme Inhibition

Amole functions as a selective non-nitrogen-containing bisphosphonate analogue. Its primary biological target is the farnesyl pyrophosphate synthase (FPPS) enzyme, a key component within the mevalonate pathway in osteoclasts. Amole binds to the active site of the FPPS enzyme. This molecular interaction initiates the mechanistic action.


Mechanistic Cascade and Osteoclast Modulation

The inhibition of FPPS prevents the synthesis of essential prenylated lipids, such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP). These lipids are necessary for the post-translational modification and activation of small signaling proteins, including GTPase Rho and Rac. The lack of activated GTPases disrupts the intracellular structure and function of the osteoclast cytoskeleton, leading to rapid osteoclast apoptosis.


System-Level Physiological Consequence

By selectively inducing the programmed death of active osteoclasts, Amole decreases the total population of these bone-resorbing cells. This reduction in osteoclast activity leads to a net decrease in the rate of bone mineral turnover. The consequence is the reduction of skeletal remodeling markers by decreasing bone resorption relative to formation, which maintains the existing bone matrix architecture.

Dosage and Administration Information

Administration Guidelines for Amole (Amlodipine)

Amole (Amlodipine) is a prescription medicine intended for chronic use. Product labeling provides specific instructions regarding its administration, dosing, and schedule.

Route, Forms, and Frequency

The medicine is administered orally (by mouth) and is available in dosage forms including tablets (2.5 mg, 5 mg, 10 mg) and an oral solution or suspension. The required frequency for use is once daily.

Dosing and Administration

Administration Condition Instruction
Standard Adult Dose 5 mg once daily (up to 10 mg maximum daily dose).
Timing Relative to Meals May be taken with or without food.
Dose Adjustment (Titration) Dosage increases are typically done gradually, over 7 to 14 days, to evaluate patient response.

Population-Specific Dosing

Administration guidelines specify lower starting doses for certain populations. A starting dose of 2.5 mg once daily is recommended for elderly or fragile patients and those with hepatic impairment. For children aged 6 to 17, the dose range is 2.5 mg to 5 mg once daily.

Handling and Missed Dose

If the oral suspension or powder for oral solution is used, product-specific instructions for shaking or reconstitution must be followed prior to measuring the dose. If a dose is missed, it should be taken as soon as it is remembered on the same day; taking two doses at the same time is not permitted.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amole (Acetaminophen/Paracetamol)

Evidence for Acute Symptom Relief (Pain and Fever)

The research base for Amole primarily consists of many Randomized Controlled Trials (RCTs) and systematic reviews that consolidated findings from these trials. Research was conducted exploring symptom patterns in conditions characterized by acute or disruptive episodes, such as mild-to-moderate pain following dental work, minor surgical procedures, or common headaches, as well as symptoms related to elevated body temperature.

In these research scenarios, studies focused on outcomes related to physical discomfort and outcomes related to systemic or functional imbalance. Specifically, researchers monitored changes in validated pain intensity scores and measured changes in body temperature over defined time intervals. Populations for these studies included both Adults and Children and Infants experiencing these acute symptom patterns. Reports detailed the time elapsed before time to initial symptom change for both pain and fever outcomes. This large volume of evidence remains focused on short-term follow-up durations, typically observing responses over periods of only a single dose or short courses of a few days.


Evidence for Chronic Pain Management

Research has also examined the compound in contexts of chronic conditions, specifically focusing on conditions marked by functional limitations, such as pain related to Osteoarthritis (OA), often involving the hip or knee. The research evaluated the compound's response over several weeks, comparing outcomes to a placebo or other options.

Trials often reported patterns showing small differences in measured pain scores and function scores compared to control groups over the course of treatment. The findings were mixed across various studies, and systematic reviews summarizing this body of work have noted that the measured changes in core outcomes were often small. This evidence contributes to the broader evidence landscape but requires careful contextualization.


What is Still Uncertain About Amole

Most available evidence comes from studies focused on short-term symptom changes, meaning long-term effects are not fully established. The follow-up durations were limited across many pivotal trials, meaning sustained patterns of symptom change over extended periods are not well characterized in the existing research. Furthermore, subgroup findings are uncertain, as the existing data provide limited insight into how patterns might differ for patients based on specific disease severity or other pre-existing health factors.

Key Studies & References Acetaminophen - StatPearls (Source for wide use and general indications/populations)

Frequently Asked Questions (FAQ)

Common questions about Amole (FAQ)

Q: How quickly should I expect to see effects from Amole?

A: Studies and official information indicate that the active ingredient in Amole is absorbed relatively quickly after oral administration. It typically reaches its highest concentration in the bloodstream within 30 to 60 minutes, which is when the onset of effect is typically observed in studies.


Q: Is Amole safe to take if I have liver problems?

A: Official regulatory documents strictly state that Amole is contraindicated (prohibited) for individuals with severe active liver disease or severe hepatic impairment. Regulatory documents indicate that use requires caution for those with other forms of liver disease or a history of chronic alcoholism.


Q: What does 'contraindicated' mean for people who cannot use Amole?

A: In medical documentation, the term 'contraindicated' signifies that a medicine should not be used under certain circumstances. It means the risks associated with the drug are considered too high for a patient, often due to a pre-existing medical condition, such as severe liver impairment, or a known allergy to the medicine.


Q: Is Amole safe for pregnant women to use?

A: Regulatory bodies have determined that the medicine is conditionally permitted for use during pregnancy only if there is a clear clinical need and it is required by a healthcare professional. When used during pregnancy, the official principle is to employ the lowest possible dose for the shortest possible duration.


Q: How long does Amole stay in your system after stopping?

A: The active substance in Amole has a relatively short elimination half-life, meaning it is processed quickly by the body. Official regulatory documents indicate that approximately 98% of a standard dose is typically eliminated from the body and no longer active within 24 hours of administration.


Q: Are the common side effects of Amole serious?

A: When used correctly and within the recommended therapeutic dose, the most commonly reported adverse reactions documented in official sources include gastrointestinal issues like nausea and vomiting. Serious adverse reactions, such as acute liver failure or severe skin reactions, are officially documented but are classified as rare or very rare events.


Q: Does taking Amole affect blood sugar levels?

A: While the active ingredient in Amole does not typically raise a person's actual blood sugar when measured by standard means, official warnings indicate it can interfere with Continuous Glucose Monitors (CGM). This interference may cause the monitor to display a falsely elevated glucose reading.


Q: Can Amole cause a change in mood or behavior?

A: Official regulatory documents do not list changes in mood or aggressive behavior as common adverse reactions. However, some general side effects documented under the Nervous System, such as headache or dizziness, may be reported. Any unusual effects should be discussed with a healthcare provider.


Q: Why is Amole sometimes prescribed alongside other medications?

A: The active ingredient in Amole is frequently included in formulations that combine it with other medicines. Regulatory approval exists for combination products—such as those containing an opioid or an antihistamine—that are designed to provide relief for conditions that require more than one type of therapeutic action.


Q: Can Amole cause stomach upset or nausea?

A: Yes, regulatory sources and clinical studies consistently document that nausea and vomiting are among the most frequently reported adverse reactions associated with Amole use. They are listed in the official safety profile.


Q: Is Amole intended for long-term use?

A: Official guidance indicates that Amole is generally intended for short-term use for the symptomatic relief of acute conditions like fever or minor pain. Official warnings exist stating that use exceeding the duration described in the product information is associated with an increased risk of serious adverse effects, particularly liver damage.


Q: Is Amole a controlled substance?

A: Amole, when used as a single ingredient, is not classified as a controlled substance by regulatory agencies. However, if Amole is compounded or formulated with certain other ingredients, such as an opioid like codeine, the resulting combination product is subject to controlled substance classification.


Q: Does Amole interact with common supplements like vitamin C?

A: Regulatory drug interaction profiles focus primarily on interactions with prescription drugs and specific food products. While a direct interaction with common supplements like Vitamin C is not typically listed, official guidance advises patients to inform a healthcare provider about all vitamins, supplements, and herbal products being taken.


Q: Is there a possibility of becoming dependent on Amole?

A: No. Regulatory classification and clinical data for the single-ingredient formulation of Amole do not indicate a potential for physical dependence or addiction. This potential is only associated with certain combination products that may include substances classified as controlled substances, such as opioids.


Q: Does Amole affect sleep patterns?

A: When taken alone, Amole's active ingredient is not generally associated with changes in sleep patterns. It is important to note that combination products may contain other components, such as caffeine, which are known to potentially interfere with sleep.


Q: What if Amole doesn't seem to be working after a few weeks?

A: Official guidance often specifies a limited duration of use for acute symptoms. Product information indicates that persistent or worsening symptoms over the defined duration may require re-evaluation by a healthcare professional.


Q: How often is Amole usually taken?

A: Official administration documents describe the use of Amole as typically taken on an 'as needed' basis for symptomatic management. The frequency of use is outlined in the official prescribing information, which also defines a maximum allowable dose per day.


Q: Can Amole affect my ability to drive?

A: Regulatory documents list some side effects, such as dizziness and headache, which may potentially impair alertness. Patients who experience any side effect that may affect their ability to concentrate or react are advised to exercise caution when operating machinery or driving.


Q: What should I do if a side effect seems mild?

A: Official guidance primarily emphasizes immediately seeking emergency medical attention if signs of a serious adverse reaction, such as an allergic reaction, liver damage, or severe skin reaction, begin to occur. For mild effects, patients are typically advised to report them to a healthcare provider at their next appointment.

How should Amole be stored and disposed of?

Official Storage and Disposal Requirements

Official labeling for Amole (Acetaminophen/Paracetamol) mandates specific conditions to maintain product integrity and ensure safe handling. The medicine must be stored at controlled room temperature, typically between 20°C and 25°C. Protection from moisture and excessive heat is required. The product container must be kept tightly closed, and the medicine should remain in its original, child-resistant packaging.

Storage Constraint Requirement
Temperature Controlled Room Temperature (20°C to 25°C)
Protection Protect from moisture and excessive heat; Do not freeze
Child Safety Keep out of the sight and reach of children
Disposal Use a drug take-back program or follow the FDA's household disposal procedure

Disposal of unused or expired Amole should prioritize a drug take-back program. If this option is unavailable, the FDA requires mixing the medicine with an unappealing substance, sealing it in a bag, and discarding it in household trash. The product must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amole found in:

A-Z Index: